Navigation Links
Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography

CROWN POINT, Ind., July 10, 2014 /PRNewswire/ -- Franciscan St. Anthony Health-Crown Point recently expanded its use of capnography for respiratory monitoring outside the operating room, joining a growing group of healthcare leaders in embracing state-of-the-art patient safety technology.

Capnography measures how effectively patients are breathing and can alert medical caregivers when life-threatening respiratory depression occurs. By measuring the amount of carbon dioxide the patient is exhaling, capnography serves as the earliest indication of evolving respiratory compromise, which can lead to significant morbidity or even cardiopulmonary arrest if undetected.

Long used in operating rooms to monitor patients under general anesthesia, hospitals committed to patient safety are now deploying capnography to monitor the quality of patients' breathing in other care areas where respiratory depression may occur. Early indication of respiratory depression with capnography enables medical staff to intervene before serious adverse events happen.

The Joint Commission, the nation's leading hospital accreditation organization; the American Society of Anesthesiologists and the Institute for Safe Medication Practices have all recommended monitoring exhaled carbon dioxide with capnography to detect respiratory depression.

Franciscan St. Anthony Health is among the nation's leaders in the early implementation of capnography monitoring outside of the operating room.

"Franciscan St. Anthony Health always has made patient safety its top priority. The decision to expand capnography use outside of our operating rooms further demonstrates this pledge through excellent care using superior technology," hospital President David Ruskowski said. "We are glad to add this advanced equipment that will give our physicians and staff the latest tool to enhance patient outcomes."

Franciscan St. Anthony Health chose capnography equipment from Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices.

"We commend Franciscan St. Anthony Health-Crown Point for joining hospitals across the nation committed to patient safety through the use of capnography," said Matt Anderson, Vice President and General Manager, Respiratory and Monitoring Solutions for Covidien. "And we appreciate its choice of Covidien's capnography technology as an excellent choice for monitoring patients."

About Franciscan St. Anthony Health-Crown Point 

Franciscan St. Anthony Health-Crown Point is part of Franciscan Alliance. A trusted leader in providing faith-based, integrated health care, Franciscan Alliance brings together the latest technology, innovative procedures and the brightest, most compassionate people to serve our patients in Indiana, Illinois and Michigan. Throughout 13 hospitals and many medical practices, Franciscan Alliance offers a number of nationally recognized Centers of Health Care Excellence.

For more than 135 years, Franciscan Alliance has stayed true to a founding mission to care for everyone, who comes through its doors. Patients receive the best possible care through practices that follow the guiding, ethical values embodied by its founding congregation, the Sisters of St. Francis of Perpetual Adoration. Always mindful of Christian stewardship to the Roman Catholic Church, Franciscan Alliance ministers with joy, care and compassion according to the ideals of St. Francis of Assisi and its founder, Mother Maria Theresia Bonzel. 

SOURCE Franciscan Alliance
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Dwaine Rieves, MD, Anthony Di Santo, PhD and Joachim Vollmar, MSc Join NDA Partners as Premier Expert Consultants
2. Anthony A. Charity Joins Tunnell Consulting
3. Spherix CEO, Anthony Hayes Appears on Bloombergs "Taking Stock With Pimm Fox"
4. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
5. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
6. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
7. New research points to benefits of innovative cobasĀ® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
8. Elsevier / MEDai Appoints Tom Zajac as New President
9. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
10. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
11. BioStorage Technologies Appoints New Member to Board of Directors
Post Your Comments:
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... a biotechnology company developing bioengineered organ implants for life-threatening ... will present at the LD Micro "Main Event" investor ... PT. The presentation will be webcast live and posted ... also be available at the conference for one-on-one meetings ...
(Date:11/25/2015)... ... November 25, 2015 , ... A long-standing ... Aerospace Professionals (OPBAP) has been formalized with the signing of a Memorandum of ... with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, November 24, ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... Oct. 29, 2015 Daon, a global leader ... has released a new version of its IdentityX ... North America have already installed IdentityX ... includes a FIDO UAF certified server component ... to activate FIDO features. These customers include some of ...
Breaking Biology News(10 mins):